https://www.selleckchem.com/pr....oducts/beta-nicotina
udy adds to existing evidence that SAO scientific activity does not contribute to public health goals, but does present industry with public relations opportunities. To describe clinical and molecular findings in fetuses with localized overgrowth disorders (LOD) involving the brain (BO) and/or a limb (LO) diagnosed on prenatal imaging (ultrasonography or MRI), suggesting involvement of the PI3K-AKT-mTOR signaling pathway. We retrospectively analyzed data from 21 fetuses with BO and/or LO referred for next-genera